| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/23/2004 | CN1507441A Tricyclic alkylhydroxamates, their preparation and thier use as well proliferation inhibitors |
| 06/23/2004 | CN1507436A Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 06/23/2004 | CN1507435A Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507355A Combination therapy using anti-EGFR antibodies and anti-hormonal agents |
| 06/23/2004 | CN1507349A Medicaments containing a polyamine as an active substance |
| 06/23/2004 | CN1506375A Azurin as bacterial protein with wide-spectrum antitumor function and its use and medicinal composition |
| 06/23/2004 | CN1506373A Composition, extraction process and use of total triterpene sapogenin extracted from bamboo |
| 06/23/2004 | CN1506360A Method of extracting effective components in kudzu vine root |
| 06/23/2004 | CN1506359A Coumarin amide derivative and its prepn, medicinal composition and use |
| 06/23/2004 | CN1506355A Diphenyl benzimidazole compound containing sulfonyl group and its prepn process, medicinal composition and use |
| 06/23/2004 | CN1506117A Antitumor genetic transcription regulating medicine |
| 06/23/2004 | CN1506109A Chinese medicine capsule for treating hemopathy and its prepn |
| 06/23/2004 | CN1506067A Application of chitin oligose in anticancer drug |
| 06/23/2004 | CN1506051A Antitumor use of diosgenin |
| 06/23/2004 | CN1154652C 5-imino-13-doxy anthracycline derivatives, their uses, and processes for preparing them |
| 06/23/2004 | CN1154648C Stable crystal salt of 5-methyl tetrahydrofolic acid |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154512C Polymeric derivatives of camptothecins |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/23/2004 | CN1154507C Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 06/23/2004 | CN1154499C 13-Deoxyanthracycline derivatives and processes for preparing them |
| 06/23/2004 | CN1154497C Method of treatment of lever tumours and pharmaceutical compositions for use therein |
| 06/23/2004 | CN1154494C Adenosine A3 receptor modulators |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/23/2004 | CN1154486C Application of thyroxine analogues method of treating malignant tumours with thyroxine analogues having no significant hormonal activity |
| 06/23/2004 | CN1154483C Use of amines to produce drugs for preventing tumour cell proliferation |
| 06/22/2004 | US6753345 7-hexanolytaxol and methods for preparing the same |
| 06/22/2004 | US6753342 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753329 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 06/22/2004 | US6753328 Liver cancer; administering taurolidine |
| 06/22/2004 | US6753327 Neurodegenerative disorder or neuronal damage treatment; inhibitors of calpain or cathepsin cysteine proteases; antiischemic agents; reperfusion injuries |
| 06/22/2004 | US6753321 Method of modulating neovascularization |
| 06/22/2004 | US6753316 Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents |
| 06/22/2004 | US6752981 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to the phosphorus in the c3n2p or c3o2p ring |
| 06/22/2004 | CA2210620C Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 06/22/2004 | CA2153422C Dehydrogenation processes and equipment therefor |
| 06/22/2004 | CA2114113C Cardiac output probe assembly |
| 06/17/2004 | WO2004050890A1 Process for producing macrolide compound |
| 06/17/2004 | WO2004050868A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof |
| 06/17/2004 | WO2004050698A2 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 06/17/2004 | WO2004050681A2 Kinase modulators |
| 06/17/2004 | WO2004050678A2 Compounds resistant to metabolic deactivation and methods of use |
| 06/17/2004 | WO2004050665A1 Silicon compounds |
| 06/17/2004 | WO2004050659A1 Novel compounds as pharmaceutical agents |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050642A1 1, 2, 3- triazole amide derivatives as cytokine inhibitors |
| 06/17/2004 | WO2004050125A1 Inhibitor of proliferation and/or infiltration of tumor cells |
| 06/17/2004 | WO2004050118A1 Cysteine protease inhibitor |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050113A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE |
| 06/17/2004 | WO2004050100A1 Method for treating a tumor using a thermo-gelling chitosan composition |
| 06/17/2004 | WO2004050098A1 Freeze-dried preparation of stabilized anthracycline compound |
| 06/17/2004 | WO2004050097A1 Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis |
| 06/17/2004 | WO2004050096A2 Phosphoantigens for regulating an immune response |
| 06/17/2004 | WO2004050095A1 Use of a known substance for the treatment of cancer and bacterial and fungal infections |
| 06/17/2004 | WO2004050089A1 Epothilone analogs for site specific delivery in the treatment of proliferative diseases |
| 06/17/2004 | WO2004050086A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 06/17/2004 | WO2004050082A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 06/17/2004 | WO2004050081A1 Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases |
| 06/17/2004 | WO2004050057A2 An exopolysaccharides delivery system for active molecules |
| 06/17/2004 | WO2004033465B1 2' oxo-voruscharin and derivatives thereof |
| 06/17/2004 | WO2004032911A3 Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor |
| 06/17/2004 | WO2004029089A3 Novel angiogenesis target and uses thereof |
| 06/17/2004 | WO2004027421A3 Adp assay |
| 06/17/2004 | WO2004026229A3 Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003063770A9 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/17/2004 | WO2003053334A3 Compositions and methods for the diagnosis and treatment of tumor |
| 06/17/2004 | WO2003018632A3 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 06/17/2004 | WO2003015813A3 Anti-tumor vaccines |
| 06/17/2004 | WO2002102309A3 Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders |
| 06/17/2004 | WO2002086443A8 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 06/17/2004 | US20040116738 Conjugated unsaturated glyceride mixtures and a method for producing the same |
| 06/17/2004 | US20040116718 Therapy for breast cancer; plant extracts |
| 06/17/2004 | US20040116716 Antioxidant from natural source |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116636 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 06/17/2004 | US20040116520 Anti-stress agents |
| 06/17/2004 | US20040116516 Pharmaceutical composition |
| 06/17/2004 | US20040116514 Carotenoid compounds and vitamin E compounds; preventing progression of hepatic disease such as cirrhosis to hepatic cancer; lycopene, beta -carotene, alpha-carotene, other natural carotenoids, and alpha -tocopherol |
| 06/17/2004 | US20040116499 treatment of inflammatory or proliferative diseases of the skin and other organ systems; from yeast of the genus Malassezia; for example, 2,3-dihydro-4,5-bis(indol-3-yl)furan-2,3-dione; against multiresistent staphylococci |
| 06/17/2004 | US20040116497 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 06/17/2004 | US20040116495 Compounds and methods |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116474 Novel pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 06/17/2004 | US20040116473 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases |
| 06/17/2004 | US20040116472 inhibit angiogenesis, tumor metastasis and growth, osteoporosis, Paget's disease, hypercalcemia of malignancy, retinopathy, macular degeneration, arthritis, periodontal disease, smooth muscle cell migration and viral diseases |
| 06/17/2004 | US20040116462 Antiinflammatory agents |
| 06/17/2004 | US20040116460 Anticancer agents |
| 06/17/2004 | US20040116458 Chemical compounds |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116448 Substances for the therapy of diseases caused by highly proliferating cells |
| 06/17/2004 | US20040116442 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/17/2004 | US20040116440 Useful for diagnosis, treatment of male or female sexual dysfunction |
| 06/17/2004 | US20040116438 Compositions for treatment of cell proliferation disorders |